Skip to main content

Articles

Page 1 of 17

  1. Concurrent opioid and stimulant use is on the rise in North America. This increasing trend of use has been observed in the general population, and among people released from prison in British Columbia (BC), wh...

    Authors: Heather Palis, Bin Zhao, Pam Young, Mo Korchinski, Leigh Greiner, Tonia Nicholls and Amanda Slaunwhite
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:77
  2. Nevada, like the rest of the United States, is undergoing substantial challenges with opioid misuse and overdose deaths, further exacerbated by the COVID-19 pandemic. While much of the attention around opioid ...

    Authors: Tessa Swigart and Lisa Lee
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:76
  3. Despite increasing substance use globally, substance use treatment utilisation remains low. This study sought to explore and measure substance use treatment barriers among young adults in South Africa.

    Authors: Tichaenzana Nyashanu and Maretha Visser
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:75
  4. Workforce diversity is a key strategy to improve treatment engagement among members of racial and ethnic minority groups. In this study, we seek to determine whether workforce diversity plays a role in reducin...

    Authors: Erick G. Guerrero, Yinfei Kong, Jemima A. Frimpong, Tenie Khachikian, Suojin Wang, Thomas D’Aunno and Daniel L. Howard
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:74
  5. COVID-19 dramatically limited the scale and scope of local health department (LHD) work, redirecting resources to the response. However, the need for essential public health services—including substance use pr...

    Authors: Kellie Hall, Francis Higgins, Karla Feeser Beach, Kabaye Diriba, Mandy Sladky and Timothy C. McCall
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:73
  6. According to the National Alcohol Beverage Control Association, twelve states in the United States (U.S.) have government retail monopolies on spirits/liquor sales. With a new federal minimum legal sales age f...

    Authors: Katherine J. Karriker-Jaffe, Lisa Henriksen, Elizabeth A. Smith, Patricia A. McDaniel, Ruth E. Malone and William C. Kerr
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:72
  7. Based on the US DARE-kiR, a version of the Keepin’ it REAL program, the Drug and Violence Resistance Educational Program (PROERD) is the most widely implemented Brazilian prevention program. It originates from...

    Authors: Julia D Gusmoes, Rodrigo Garcia-Cerde, Juliana Y Valente, Ilana Pinsky and Zila M Sanchez
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:71
  8. To evaluate provider perspectives on the development and implementation of an inpatient Addiction Medicine Consult Service, including their awareness of the service, its perceived role in the continuum of care...

    Authors: Madelaine Beckett, Ramm Hering and Karen Urbanoski
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:70
  9. According to a landmark decision by the Swiss Federal Supreme Court, people with a substance use disorder (SUD) are now eligible for disability benefits if their disorder impairs their ability to work. Alcohol...

    Authors: Helen Wyler, Anja Maisch, Thomas Berger, Ueli Kieser, Roman Schleifer and Michael Liebrenz
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:69
  10. There is a higher prevalence of substance use disorder (SUD) among justice-involved children (JIC). It is critical to ensure that JIC who report current use are referred for SUD assessment and potentially life...

    Authors: Micah E. Johnson, Shawnta L. Lloyd, Skye C. Bristol, Amy L. Elliott and Linda B. Cottler
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:68
  11. There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a sec...

    Authors: Llewellyn Mills, Adrian Dunlop, Mark Montebello, Jan Copeland, Raimondo Bruno, Meryem Jefferies, Iain Mcgregor and Nicholas Lintzeris
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:67
  12. Novel public health interventions are needed to address the toxic drug supply and meet the needs of people who use drugs amidst the overdose crisis. Safer supply – low-barrier distribution of pharmaceutical gr...

    Authors: Annie Foreman-Mackey, Bernie Pauly, Andrew Ivsins, Karen Urbanoski, Manal Mansoor and Geoff Bardwell
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:66
  13. Several reports have described a growing prevalence of illicit drug use in Afghanistan, with recognition of a recent shift from traditional modes of consumption involving inhalation and oral ingestion to injec...

    Authors: Frishta Nafeh, Sufiat Fusigboye and Bundit Sornpaisarn
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:65
  14. Authors: Nathalie Kools, Guus G. Dekker, Brenda A. P. Kaijen, Bert R. Meijboom, Rob H. L. M. Bovens and Andrea D. Rozema
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:64

    The original article was published in Substance Abuse Treatment, Prevention, and Policy 2022 17:59

  15. The aim of this study was to examine the effect of a practice change intervention to support the implementation of guideline-recommended care for addressing alcohol use in pregnancy on self-reported alcohol us...

    Authors: Tracey W. Tsang, Melanie Kingsland, Emma Doherty, John Wiggers, John Attia, Luke Wolfenden, Adrian Dunlop, Belinda Tully, Ian Symonds, Chris Rissel, Christophe Lecathelinais and Elizabeth J. Elliott
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:63
  16. People living in rural and remote communities in Canada are often disproportionately impacted by opioid use disorder. When compared to urban centres, rural and remote populations face additional barriers to tr...

    Authors: Em M. Pijl, Abeer Alraja, Elsie Duff, Carol Cooke, Stephen Dash, Nichole Nayak, Jesse Lamoureux, Ginette Poulin, Erin Knight and Ben Fry
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:62
  17. Appointment no-show and early dropout from treatment represent major challenges in outpatient substance use disorder treatment, adversely affecting clinical outcomes and health care productivity. In this quasi...

    Authors: Lisbeth Jensen Gallefoss, Karin Berle Gabrielsen, Siri Håvås Haugland, Thomas Clausen and John-Kåre Vederhus
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:61
  18. Provision of aftercare services for persons with substance use disorders (PWSUD) within a rural context is typically met with various intersecting challenges, including unclear policy implications and lack of ...

    Authors: December Mandlenkosi Mpanza, Pragashnie Govender and Anna Voce
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:60
  19. Interdisciplinary collaborations (i.e., where various disciplines work coordinated and interdependently toward shared goals) are stated to yield higher team effectiveness than multidisciplinary approaches (i.e...

    Authors: Nathalie Kools, Guus G. Dekker, Brenda A. P. Kaijen, Bert R. Meijboom, Rob H. L. M. Bovens and Andrea D. Rozema
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:59

    The Correction to this article has been published in Substance Abuse Treatment, Prevention, and Policy 2022 17:64

  20. There is a growing evidence base around predictors of retention and completion in a range of recovery residence models, particularly Oxford Houses and Sober Living Houses, and recovery housing is recognized as...

    Authors: Sofia Härd, David Best, Arun Sondhi, John Lehman and Richard Riccardi
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:58
  21. In Colombia, a person caught in possession of an illicit substance is not judicially sanctioned as long as the quantity does not exceed the maximum allowable amounts. Given that the public is divided on the ap...

    Authors: Daniel del Rio Forero, Claudia Pineda Marín, María Teresa Muñoz Sastre, Lonzozou Kpanake and Etienne Mullet
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:57
  22. Canada and the United States continue to experience increasing overdose deaths attributed to highly toxic illicit substances, driven by fentanyl and its analogues. Many bystanders report being hesitant to call...

    Authors: Bradley Kievit, Jessica C. Xavier, Max Ferguson, Heather Palis, Soroush Moallef, Amanda Slaunwhite, Terri Gillis, Rajmeet Virk and Jane A. Buxton
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:56
  23. Beginning in the 1990s, nonmedical use of prescription opioids (POs) became a major public health crisis. In response to rising rates of opioid dependence and fatal poisonings, measures were instituted to decr...

    Authors: Julia Dickson-Gomez, Sarah Krechel, Antoinette Spector, Margaret Weeks, Jessica Ohlrich, H. Danielle Green Montaque and Jianghong Li
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:55
  24. Outdoor smoke-free policies (SFPs) at sports clubs can contribute to protecting people from second-hand smoke (SHS). However, in absence of national legislation, it is uncertain whether and how sports clubs de...

    Authors: Heike H. Garritsen, Andrea D. Rozema, Ien A. M. van de Goor and Anton E. Kunst
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:54
  25. Although several studies have found a high incidence of coexisting mental health problems among adolescents with substance use problems, follow-up studies addressing how these conditions change over time are r...

    Authors: Karin Boson, Mats Anderberg, Johan Melander Hagborg, Peter Wennberg and Mikael Dahlberg
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:53
  26. In recent years, female drinking has been on the rise worldwide, and this trend can be observed in Korea as well. Accordingly, this study aimed to examine the heterogeneous longitudinal changes in drinking pat...

    Authors: Soo-Bi Lee, Hyung-Joo Park and Myeong-Sook Yoon
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:52
  27. In the United States, access to buprenorphine remains low and disparities regarding who receives treatment have emerged. Federal laws have regulated buprenorphine delivery, ultimately limiting its implementati...

    Authors: Barrot H. Lambdin, David Kan and Alex H. Kral
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:51
  28. The study aimed to identify the missed opportunity for detection and management of alcohol use disorder by primary health care workers.

    Authors: Dorothy Mushi, Candida Moshiro, Charlotte Hanlon, Joel M. Francis and Solomon Teferra
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:50
  29. As Medicaid is the largest payer for opioid use disorder (OUD) treatment services in the United States, information about Medicaid provider reimbursement is critical, and Medicaid payment policies influence th...

    Authors: Lisa Clemans-Cope, Victoria Lynch, Maya Payton and Joshua Aarons
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:49
  30. Authors: David L. Driscoll, Alison Evans Cuellar, Vinod Agarwal, Debra Jones, Mary Beth Dunkenberger and Kathy Hosig
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:46

    The original article was published in Substance Abuse Treatment, Prevention, and Policy 2022 17:26

  31. There has been a paradigm shift in the treatment of Hepatitis C (HCV) from the interferon-era to direct-acting antiviral (DAA) drugs. Cure of HCV for the key risk group, those with a history of injecting drug ...

    Authors: Sarah R. Donaldson, Andrew Radley and John F. Dillon
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:45
  32. Hepatitis C virus (HCV) is common among individuals in opioid agonist therapy (OAT). HCV treatment has previously been unavailable for most HCV positive OAT patients in Finland. The removal of treatment restri...

    Authors: Margareeta Häkkinen, Jouni Tourunen, Tuuli Pitkänen, Kaarlo Simojoki and Sauli Vuoti
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:44
  33. Substance use among youth (ages 12–24) is troublesome given the increasing risk of harms associated. Even more so, substance use services are largely underutilized among youth, most only accessing support when...

    Authors: Roxanne Turuba, Anurada Amarasekera, Amanda Madeleine Howard, Violet Brockmann, Corinne Tallon, Sarah Irving, Steve Mathias, Joanna Henderson, Kirsten Marchand and Skye Barbic
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:43
  34. Bystanders to drug overdoses often avoid or delay calling 9–1-1 and cite fear of police involvement as a main reason. In 2017, the Good Samaritan Drug Overdose Act (GSDOA) was enacted by the Canadian government t...

    Authors: Emma Ackermann, Bradley Kievit, Jessica Xavier, Skye Barbic, Max Ferguson, Alissa Greer, Jackson Loyal, Zahra Mamdani, Heather Palis, Bernie Pauly, Amanda Slaunwhite and Jane A. Buxton
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:42
  35. Opioid overdose remains a public health crisis in diverse communities. Between 2019 and 2020, there was an almost 40% increase in drug fatalities primarily due to opioid analogues of both stimulants and opioid...

    Authors: Katherine A. Hirchak, Solmaz Amiri, Gordon Kordas, Oladunni Oluwoye, Abram J. Lyons, Kelsey Bajet, Judith A. Hahn, Michael G. McDonell, Aimee N. C. Campbell and Kamilla Venner
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:41
  36. Recently developed buprenorphine depot injections have the potential to reduce risk for diversion and misuse, and to increase adherence with fewer visits for supervised intake. However, it is unclear how patie...

    Authors: Björn Johnson, Olivia Liahaugen Flensburg and Andrea Johansson Capusan
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:40
  37. Evidence suggests people who inject drugs (PWID) prescribed opioid agonist treatment (OAT) are less likely to provide injection drug use (IDU) initiation assistance. We investigated the association between OAT...

    Authors: Stephanie A. Meyers-Pantele, Maria Luisa Mittal, Sonia Jain, Shelly Sun, Indhu Rammohan, Nadia Fairbairn, M-J Milloy, Kora DeBeck, Kanna Hayashi and Dan Werb
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:39
  38. Certificate-of-need (CON) laws in place in most US states require healthcare providers to prove to a state board that their proposed services are necessary in order to be allowed to open or expand. While CON l...

    Authors: James Bailey, Thanh Lu and Patrick Vogt
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:38
  39. International drug policy is rapidly evolving in tandem with promising evidence for psychedelic-assisted psychotherapy (PAP) in treating a range of mental health conditions. Canada is among the countries incre...

    Authors: Victor Mocanu, Lindsay Mackay, Devon Christie and Elena Argento
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:37
  40. Approximately 3.8% of adults worldwide have used cannabis in the past year. Understanding how cannabis use is associated with other health conditions is crucial for healthcare providers seeking to understand t...

    Authors: Howard Padwa, David Huang, Larissa Mooney, Christine E. Grella, Darren Urada, Douglas S. Bell, Brittany Bass and Anne E. Boustead
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:36
  41. It is critical to develop empirically based, community-treatment friendly, psychotherapy interventions to improve treatment for patients with comorbid chronic pain and Opioid Use Disorder. Understanding factor...

    Authors: Amy Wachholtz, Dallas Robinson and Elizabeth Epstein
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:35
  42. Evidence continues to show that young people, ages 15-24, remain at significant risk of harms from non-medical opioid use and opioid use disorder (OUD), with experts calling for widespread implementation of de...

    Authors: Kirsten Marchand, Roxanne Turuba, Christina Katan, Chantal Brasset, Oonagh Fogarty, Corinne Tallon, Jill Fairbank, Steve Mathias and Skye Barbic
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:34
  43. Patterns of movement, heterogeneity of context, and individual space-time patterns affect health, and individuals’ movement throughout the landscape is shaped by addiction, meeting basic needs, and maintaining...

    Authors: Jill Owczarzak, Jessie Chien, Karin Tobin, Alyona Mazhnaya, Olena Chernova and Tetiana Kiriazova
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:33
  44. Although Kazakhstan National Anti-Doping Organization (KazNADO) exists since 2013, but little is yet known about anti-doping (AD) knowledge of Kazakhstan athletes. The aim of this study was to assess the AD educa...

    Authors: Galiya Zhumabayeva, Gulnara Kapanova, Denis Vinnikov, Maira Bakasheva, Venera Abdulla and Andrej Grjibovski
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:32
  45. This study aimed to evaluate the effects of the World Anti-Doping Agency's e-learning programme for anti-doping education on knowledge of, explicit and implicit attitudes towards, and likelihood of doping amon...

    Authors: Zhangyan Deng, Jinyang Guo, Dong Wang, Tao Huang and Zuosong Chen
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:31
  46. Drug-related psychiatric comorbidity or death among adolescents has grown to become a public health threat in Taiwan. In an atmosphere of abstinence, few alternatives or rehabilitative options for troubled you...

    Authors: Lanying Huang
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:30
  47. Tobacco control program leaders and their partners, who often present evidence to policymakers, can increase the use of evidence in program and policy development. However, up-to-date evidence from the scienti...

    Authors: Virginia Mckay, Mia Vogel, Todd Combs, Laura Brossart, Amy Endrizal, Stephanie Andersen, Timothy Poor, Margaret Mahoney and Douglas Luke
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:29
  48. Neurofeedback (NF) has been described as “probably efficacious” when used in conjunction with other interventions for substance use disorders, including the recent studies in the population of individuals with...

    Authors: Helena A. Rempala and Justin A. Barterian
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:28

Annual Journal Metrics